Clinical Trial Update: Polyunsaturated Fatty Acids in Treating Patients With Prostate Cancer Undergoing Prostate Biopsy and/or Surgery [NA]

View source ↗

Summary

This update notes that the Dana-Farber Cancer Institute's trial evaluating polyunsaturated fatty acids in men with prostate cancer undergoing biopsy and/or surg…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Polyunsaturated fatty acids (PUFA)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Prostate Cancer | NA | Status: TERMINATED